SB Investment Advisers (uk) Ltd., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 350,129 shares at $26.13 ($9.1M) on 2022-12-22, disclosed to the SEC on 2022-12-27.
Open-market sale of $9.1M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.87 | 22,801 | $590K | 6.5% |
| 2 | $25.87 | 22,801 | $590K | 6.5% |
| 3 | $26.13 | 72,343 | $1.9M | 20.8% |
| 4 | $26.13 | 72,343 | $1.9M | 20.8% |
| 5 | $25.76 | 79,760 | $2.1M | 22.6% |
| 6 | $25.76 | 79,760 |
| $2.1M |
| 22.6% |
| 7 | $26.07 | 321 | $8K | 0.1% |
| Total | $25.93 avg | 350,129 | $9.1M | 100% |
| Filing → |
| VIR | SELL | 2025-10-24 | $3.6M | — | Filing → |
| VIR | SELL | 2025-10-09 | $6.4M | — | Filing → |
| CPNG | SELL | 2025-06-17 | $282.5M | — | Filing → |